Samit Hirawat, MD - Bristol Myers Squibb

 

Samit Hirawat, MD

Executive Vice President, Chief Medical Officer, Global Drug Development
 

As chief medical officer, Global Drug Development, Dr. Samit Hirawat oversees late-stage product development across all therapeutic areas. In this role, Samit and his organization focus on enabling the rapid progression and delivery of late-stage assets, from proof-of-concept to commercialization, through world-class clinical trial design and operations. He also currently serves as the executive sponsor of the Cultivating Leadership for Millennials and Beyond (CLIMB) People and Business Resource Group. 

Samit joined Bristol Myers Squibb in 2019 with extensive drug development experience, most recently serving as Executive Vice President and Head of Oncology Development for Novartis. Previously, he led clinical development programs in multiple indications at PTC Therapeutics and Pfizer/Pharmacia Corporation.

Samit earned his bachelor of medicine, bachelor of surgery (MBBS) at Sawai Man Singh Medical College in India, and completed his internal medicine residency and medical oncology training at North Shore University Hospital, New York.

Updated: November 2021


PREVIOUS